Significance of methotrexate serum level achieved in patients with gastrointestinal malignancies treated with sequential methotrexate, l-folinic acid and 5-fluorouracil

Oncology (Switzerland)

Volumn 53, Issue 3, 1996, Pages 198-203

  Comella, Pasquale ^a   Palmieri, Giuseppe ^a   Beneduce, Gerardo ^a   Casaretti, Rossana ^a   Daponte, Antonio ^a   Gravina, Adriano ^a   Frasci, Giuseppe ^a   Biondi, Edoardo ^a   Comella, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

5 Fluorouracil; Biochemical modulation; Gastrointestinal carcinoma; Methotrexate

Indexed keywords

FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DIGESTIVE SYSTEM CANCER; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; GASTROINTESTINAL NEOPLASMS; HUMANS; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED;

EID: 0029881561     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227560     Document Type: Article

References (31)

1. Mocrtcl CG: Chemotherapy of gastrointestinal cancer, N Engl J Med 1978;299:1049-1052.
2. Diaz-Rubio E, Jimcno J, Antón A, Aranda E, Sanchez J, Massuti B, Cruz-Hernandez J, C'ar-rato A, Martin M, Felon J, Gonzalez R, Milla A, Sanchiz F, Balana C, Lizon J, Diaz-Faez J, Alonso A, Navarrete A, Sanz Ortiz J, Camps C, Del Moral F: A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5FU plus cisplatin in patients with advanced colorectal cancer, Am J Clin Oncol 1992:15:56-60.
3. Kim NK, Park YS, Heo DS, Suh C, Kim SY, Park KC, Kang YK, Shin B, Kim HT, Kim HY, Kang WK, Suh Cl, Bang YJ: A phase III randomized study of 5-fluorouracil and cisplatin versus fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer, Cancer 1993;71:3813-3818.
4. Kemeny N, Israel K, Nicdzwiecki D, Chapman D, Botet J, Minsky B: Randomized study of continuous infusion flurouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer, J Clin Oncol 1990:8:313- 316.
5. Peters GJ, Van Groeningen CJ: Clinical relevance of biochemical modulation of 5-fluorouracil, Ann Oncol 1991:2:469-480.
6. Buroker TR, Mocrtel CG, Fleming TR, Everson LK, Cullman SA, Krook JE, Maillard JA, Marschke RF, Klaassen DJ, Laurie JA, Moon MD: A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma, J Clin Oncol 1985:3:1624- 1631.
7. Mulder JH, Smink T, Van Putten LM: 5-fluorouracil and methotrexate combined chemotherapy: The effect of drug scheduling, Eur J Cancer Clin Oncol 1981:17:831-837.
8. Tattersall MHN: Current studies of methotrexate and 5-fluorouracil and their interaction in human tumor cells, Semin Oncol 1983: 10(suppl 2):6-10.
9. Bleycr WA: The clinical pharmacology of methotrexate: New application of an old drug, Cancer 1978:41:36-51.
10. Chabner BA: Methotrexate: in C'habncr BA (ed): Pharmacologic principles of cancer treatment, Philadelphia, Saunders, 1982. pp229-255.
11. Fernandez DJ, Moroson BA, Bcrtino JR: The role of methotrexate and dihydrofolatepolyglu-tamatcs in the enhancement of fluorouracil action by methotrexate, Cancer Treat Rep 1981: 65(suppl 1): 29-35.
12. Mini E, Coroncllo M, Carotti S, Gerii A, Pesciullcsi A, Moroson BA, Mazzei T, Periti P, Berlini JR: Biochemical modulation of fluoro-pyrimidines by antifolates and folates in an in vitro model of human leukemia, J Chemother 1990;2(suppl 1): 17-27.
13. Rustum JM: Rationale for the combination of 5-fluorouracil/leucovorin: Role of dose, schedule and route of administration: in Pinedo HM, Rustum YM (eds): Lcucovorin Modulation of Fluoropyrimidines: A New Frontier in Cancer Chemotherapy, London, Royal Society of Medicine Services, 1989. pp 11-19.
14. Radparvar S, Houghton PJ, Houghton JA: Effect of polvglutamvlation of 5.10-melhylene-tetrahydrofolate on the binding of 5-fluoro-2-deoxyuridvlate to thymidvlate synthase purified from a human colon adenocarcinoma xenograft, Biochem Pharmacol 1989:38:335- 337.
15. Madajevicz S, Avvento L: Clinical trial with 5-fluorouracil, folinic acid and cisplatin in patients withgastrointestinal malignancies, J Chemother 1990:2(suppl 1):33-37.
16. Grem JL, Hoth DF, Hamilton JM, King SA, Leyland-Jones B: Overview of current status and future direction on clinical trials with 5-fluorouracil in combination with folinic acid, Cancer Treat Rep 1987;71:1249-1253.
17. Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovo-rin in patients with advanced colorectal cancer: Evidence in terms of response rate, J Clin Oncol 1992:10:896-903.
18. Marsh JC, Bertino JR, Katz KH, Davis CA, Durivagg HJ, Rome LS, Richards F, Capizzi RL, Farber LR, Pasquale DN, Stuart R, Kolet-skv AJ, Makuch R, O'Hollaren K: The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer, J Clin Oncol 1991; 9:371-380.
19. Saidman B, Hait W, Marsh JC, Reiss M, Duri-vage H, Davis C, Makuch RW, Bertino JR, Portlock CS: Phase II study of sequential methotrexate (MTX), high dose lcucovorin (HDLV) and 5-fluorouracil (5FU) in the treatment of metastatic breast cancer, Proc Am Soc Clin Oncol 1989:8:38.
20. Abad A, Roseli R, Pastor MC, Bamadas A, Carles J, Ribclles N, Oiler B, Armengol M, Salva A, Ribas M: Sequential combination of methotrexate (MTX), 5-fluorouracil (FU) and high-dose folinic acid (FA) in advanced colorectal cancer: Double biochemical modulation? Am J Clin Oncol 1991:14:393-396.
21. Machiavelli M, Leone BA, Romero A, Rabinovich MG, Vallejo CT, Bianco A, Perez JE, Rodriguez R, Cucrvas MA, Alvarez LA, Chacon R, Hannois A: Advanced colorectal carcinoma: A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leu-covorin versus 5-fluorouracil alone, Am J Clin Oncol 1991:14:211-217.
22. Richards F, Capizzi RL, Muss H, Cruz J, Powell B, White D, Jackson D, Atkins A, Caldwell L, Puckett J, Christian E, Schnell F, Sharpe S, Stanley V, Brockschntidt J: 5-fluorouracil (5-FU), high dose folinic acid (FA) and methotrexate (MTX) for advanced colorectal cancer: A phase 11 trial of the Piedmont Oncology Association, Proc Am Soc Clin Oncol 1989:8: 101.
23. Miller AB, Hoogstratcn B, Staquet M, Winkler V: Reporting results of cancer treatment, Cancer 1981:47:207-214.
24. Hryniuk WH, Goodyear M: The calculation of received dose intensity, J Clin Oncol 1990:8: 1935-1937.
25. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations, J Am Stat Assoc 1958:53:457-461.
26. Colton T: Statistics in Medicine, Boston, Little, Brown, 1975.
27. Advanced Colorectal Cancer Meta-Analysis Project: Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer, j Clin Oncol 1994:12:960-969.
28. Labianca R, Pancera G, Aitini E, Barni S, Be-retta A, Beretta GD, Cesana D, Cornelia G, Cozzaglio L, Crisloni M, Spagnoli P, Frontini L, Gottardi O, Martignoni G, Scarpaticci R, Smerieri F, Vinci M, Zadro A, Zaniboni A, Luporini G: Folinic acid+5-fluorouracil (5-FU) versus equidosc 5-FU in advanced colorectal cancer: Phase III study of GISCAD (Italian Group for the Study of Digestive Tract Cancer), Ann Oncol 1991:2:673-679.
29. Valonc FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan F, Brown BW Jr.: Treatment of patients with advanced colorectal carcinoma with fluorouracil alone, high-dose lcucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: A randomized trial of the Northern California Oncology Group, J Clin Oncol 1989:7:1427-1436.
30. Kelsen D, Atiq OT, Saltz L, Nicdzwiecki D, Ginn D, Chapman D, Heelan R, Lightdalc C, Vinciguerra V, Brennab M: FAMTX versus etoposide, doxorubicin and cisplatin: A random assignment trial in gastric cancer: J Clin Oncol 1992:10:541-548.
31. Wils JA, Klein HO, Wagoner DJT, Bleiberg H, Res H, Korsten F, Conroy TH, Ficker M, Lcyvraz S, Buyse M, Ducz N: Sequential high-dose methotrexate and fluorouracil combined with doxorubicin: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group, J Clin Oncol 1991:9:827-831